Fundraising Fox
Find your path to Adele
Sign up to see every warm intro you have to Adele
- Paths you didn't know you had: your email and LinkedIn already hold routes to Adele. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Adele C. Oliva is a healthcare investor with more than 20 years of experience who founded 1315 Capital in 2014 to focus on healthcare growth equity and buyouts. She previously joined Quaker Partners in 2007 to build out their growth-stage investing practice and earlier served as Co-Head of US Healthcare at Apax Partners across Silicon Valley and Manhattan. She began her career at CoreStates and Baxter Healthcare, entered private equity as a Kauffman Fellow, and holds a BSc from St. Joseph's University and an MBA from Cornell University.
Contact· self-published, not guessed
Invests in
BiotechDigital HealthHealthtechMedical Devices
Deals · 6
Greenbrook TMSBoard seat
via 1315 Capital · filed Jul 2022 · $15.7M raise
Sprout2Board seat
via 1315 Capital · filed Aug 2019 · $20M raise
NovaSomBoard seat
via 1315 Capital · filed Jun 2019 · $7.5M raise
Encore DermatologyBoard seat
via 1315 Capital · filed Apr 2019 · $41.2M raise
ColorescienceBoard seat
via 1315 Capital · filed Jul 2017 · $16M raise
TELA BioBoard seat
via 1315 Capital · filed Jan 2017 · $7.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
3B ScientificAscent Healthcare SolutionsEKR TherapeuticsESP PharmaEsprit PharmaGenoptixHomestead Smart Health PlansInnovative HealthmiraDryOnkos SurgicalOnkos SurgicalPrecision DermatologyPrometheus LabsSkinMedica
Sources: the firm's website · SEC Form D filings.
Colleagues at 1315 Capital
Network2
Investors connected to Adele in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Adele C. Oliva?
- Adele C. Oliva is a healthcare investor with more than 20 years of experience who founded 1315 Capital in 2014 to focus on healthcare growth equity and buyouts. She previously joined Quaker Partners in 2007 to build out their growth-stage investing practice and earlier served as Co-Head of US Healthcare at Apax Partners across Silicon Valley and Manhattan. She began her career at CoreStates and Baxter Healthcare, entered private equity as a Kauffman Fellow, and holds a BSc from St. Joseph's University and an MBA from Cornell University.
- Where does Adele C. Oliva work?
- Adele C. Oliva is Founding Partner at 1315 Capital.
- What does Adele C. Oliva invest in?
- Adele C. Oliva invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What boards does Adele C. Oliva sit on?
- Adele C. Oliva holds tracked board seats at 3B Scientific, Ascent Healthcare Solutions, Colorescience, Colorescience, EKR Therapeutics, Encore Dermatology, ESP Pharma, Esprit Pharma, Genoptix, Greenbrook TMS.
About this profile. Compiled from public sources — 1315 Capital's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights